Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
ACE Report #7501
Ace Report Cover Hand & Wrist

AAHS 2015: Exparel vs. Marcaine for postoperative analgesia in outpatient wrist procedures

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Bupivicaine Extended-Release Liposome vs. Marcaine for Early Post-Operative Pain Control Following Wrist Operations: A Prospective Randomized Double-Blind Controlled Trial

Contributing Authors: EL Dale J Rehm J Cowart M Jemison W Kennedy M Brzezienski

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


28 patients were randomized to recieve either Exparel (bupivacaine extended-release liposome) or Marcaine (bupivacaine) following either carpometacarpal arthroplasty (CMCA) or proximal row carpectomy (PRC). The purpose of the study was to determine whether Exparel was effective in reducing pain, reducing opioid use and opioid side effects, and improving long-term hand function when compared to Mar...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.